Originally from Italy, I graduated with honours from RCSI, Ireland. In Dublin I completed my core paediatric training. At the beginning of 2010 I joined the Dubowitz Neuromuscular Centre, at the UCL Institute of Child Health and Great Ormond Street Hospital. I worked as a clinical researcher and investigator for numerous clinical trials for neuromuscular disorders, including the EU funded Skip-NMD project on antisense oligomer exon skipping (http://www.skip-nmd.eu), led by Professor Francesco Muntoni.I completed my higher degree focused on characterising the evolving natural history of Duchenne muscular dystrophy (DMD) and developing novel outcome measures for clinical trials. 

As part of my research projects I reported on the use, benefits and adverse effects of glucocorticoids in large cohorts of DMD subjects, and further delineated their cognitive and neurobehavioral profile in relation to their underlying genotype. I initiated collaborative efforts to deepen our understanding of the relationship between genotype and phenotype in DMD.  I have been an active member of international consortia, which developed new biomarkers and clinical outcome measures for neuromuscular disorders including actimeters, myometers, functional scales and muscle MR imaging. 

Currently I am  Director of Translational Research and Development at Solid Biosciences (http://solidbio.com) and involved in designing the AAV-delivered micro-dystrophin gene therapy clinical trial for DMD and developing clinical outcome measures. Furthermore, I am a trainee in the Pharmaceutical Medicine Specialty Training programme of the Royal College of Physicians of the UK. Prior to joining Solid I worked as Medical Director for the neuromuscular franchise of BioMarin Pharmaceutical Inc. and I was a consultant for the Institute of Myology, University of Pierre et Marie Curie-Sorbonne, Paris. As an Honorary Lecturer at the Great Ormond Street Institute of Child Health I remain involved in academic research and notably in developing new treatment approaches for neuromuscular diseases in children.